Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinoma in vitro and in vivo

Hepatocellular carcinoma (HCC) is a highly lethal malignancy mostly because of metastasis, recurrence and acquired resistance to conventional chemotherapy. Arsenic trioxide (ATO) is successfully used to treat hematological malignancies, and has been proven to trigger apoptosis in HCC cells. However,...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Song, Jingjing, Zhao, Zhongwei, Fan, Xiaoxi, Chen, Minjiang, Cheng, Xingyao, Zhang, Dengke, Wu, Fazong, Ying, Xihui, Ji, Jiansong
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2016
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342569/
https://ncbi.nlm.nih.gov/pubmed/27655700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12041
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki